New chance with inflammatory intestine illnesses - Probiotikum restrains inflammations in the final intestine

(openPR) - the chronic illnesses disease Crohn and Colitis summarized under the generic term of the inflammatory intestine illnesses ulzerosa are not until today by medicamentous measures welfarable. To be improved the more importantly each progress, which that approximately 300,000 concerning with chronically inflammatory intestine getting sick run gene in Germany helps to reduce the inflammation activity is the quality of life back cases to be avoided and thus. Recently Gastroenterology reported French researchers on such progress in the technical periodical. In experimental studies they could prove that the per bio tables microorganism Saccharomyces boulardii, a Probiotikum frequently used in the medicine to restrain in the situation is the inflammatory processes in the intestinal mucosa from mice to. The authors conclude from their results that a treatment can affect inflammatory intestine illnesses favorably with S. boulardii. A supplementing therapy attempt would offer the chance to control on biological way the chronic inflammation. In Germany Saccharomyces is available boulardii in caps as afterbiotic® (PZN 4604255) the company Navitum Pharma in pharmacies. Further information under www.navitum-pharma.com or Kontaktaufnahme by Mail under info@navitum.de

Source: Dalmasso G, Gastroenterology. 2006 November 4;

Navitum Pharma GmbH
At the water tower 29
65207 Wiesbaden
Tel: 0611-58939458
FAX: 0611-9505753
E-Mail: info@navitum.de
Web: www.navitum-pharma.com

Navitum Pharma develops and sells products of natural substances and micro nutrients for the health care of modern fastidious humans. The products documented and certified all on basis compound by current scientific realizations and studies. These singular rationally scientifically justified products and screening programs are explanation needy and require a competent consultation. Therefore our products and services are discussed exclusively with the physician and pharmacist, over physician and pharmacist recommended and only over the pharmacy driven out. Navitum Pharma works for the receipt of health as partner of physician and pharmacist.

The products of the Vitum line of the Navitum® Pharma are meant as preventive measure - in the sense of primary prevention - or supplementing supporting measure - also in the sense of secondary prevention - for illnesses, which can be affected nourish-medically or chemo+preventively. In addition prevention counts illnesses also ageconditioned by heart cycle illnesses, neoplastischen new formations, striking and eye illnesses, metabolic disturbances, bone and joint illnesses, immunological like. Composition and dosage of the products follow strictly scientific criteria and correspond the study situation in the appropriate area of application.
The following products of the Vitum LINE are available:

CorVitum® for the prevention of heart cycle illnesses
ProVitum® for the prevention of Prostatakarzinomen
DiaVitum® for prevention/support with diabetes mellitus
VasoVitum® for prevention/support with venous insufficiency
MemoVitum® for the prevention of ageconditioned immunological and cognitive changes
ArtVitum® for prevention/support with degenerative joint illnesses
OmVitum® for inflammation inhibition with vegetable Omega-3-Fettsäuren
Additionally afterbiotic®, a product is available for the Vorbeugung and moderating of antibiotics associated diarrheas.

Dieser Artikel wurde veröffentlicht auf
OpenPR - http://openpr.de/news/119600/Neue-Chance-bei-entzuendlichen-Darmerkrankungen-Probiotikum-hemmt-Entzuendungen-im-Enddarm.html